HADERER & MULLER
  • Portfolio
  • About
    • Team: who we are
    • Services: what we do
    • Process: how we work
    • Clients: who we work with
    • Testimonials: what they say
    • Certified Medical Illustrator
  • News
  • Contact

A gallery of our work

All Projects

Antiviral drug

  • » Next
  • Previous »

These mechanism of action (MOA) illustrations demonstrate the point in the process when antiviral drug SB 9200 (for hepatitis C) acts on the pathway to activate RIG-1 and NOD2, the proteins involved in detecting viral RNA once it has entered a cell. The subsequent cascade results in the up-regulation of the host immune response to the infection.

The illustrations were designed for presentation by the sales team and for use on their outward-facing website, so the story is presented broadly and details about exact interactions and configurations have been left out.

© Haderer & Müller Biomedical Art, LLC

  • Portfolio
  • About
  • News
  • Contacts
  • biomedart@haderermuller.com
Stay Connected
    • All content © 2018 Haderer & Muller Biomedical Art, LLC;
    • Legal Notice